Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;47(4):707-723.
doi: 10.1016/j.rdc.2021.07.008. Epub 2021 Aug 27.

Unique Aspects of Pediatric Sjögren Disease

Affiliations
Review

Unique Aspects of Pediatric Sjögren Disease

Rachel L Randell et al. Rheum Dis Clin North Am. 2021 Nov.

Abstract

Sjögren disease increasingly is recognized in pediatric patients. Clinical features, primarily parotitis and sicca symptoms, and results of diagnostic tests may be different from those in adult disease. Adult criteria fail to capture most pediatric patients. Pediatric-specific criteria are urgently needed to define the natural history of the disease, identify risk and prognostic factors, and evaluate the impact of therapeutics and other interventions on disease course in young patients.

Keywords: Parotitis; Pediatric Sjögren syndrome; Sjögren disease; Sjögren syndrome.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Focal sialadenitis on labial minor salivary gland biopsy in a child with Sjögren disease. This H&E-stained section of a minor salivary gland from an 8-year-old girl demonstrates normal glandular architecture with a focus of mononuclear cells (arrow) in the typical peri-ductal distribution. A focus is defined as an aggregate of ≥50 mononuclear cells. The focus score is defined as the number of foci per 4 mm2 of tissue, with a score of ≥1 focus/4 mm2 meeting histopathologic criteria for Sjögren disease in adults. Courtesy of Scott Steward-Tharp, DDS, PhD, University of Iowa.

References

    1. Brito-Zeron P, Baldini C, Bootsma H, et al. Sjogren syndrome. Nat Rev Dis Primers. 2016;2:16047. - PubMed
    1. Vivino FB, Bunya VY, Massaro-Giordano G, et al. Sjogren’s syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol. 2019;203:81–121. - PubMed
    1. Alani H, Henty JR, Thompson NL, Jury E, Ciurtin C. Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjogren’s syndrome (secondary Sjogren’s syndrome) focusing on autoimmune rheumatic diseases. Scand J Rheumatol. 2018;47(2):141–154. - PubMed
    1. Akpek EK, Mathews P, Hahn S, et al. Ocular and systemic morbidity in a longitudinal cohort of Sjogren’s syndrome. Ophthalmology. 2015;122(1):56–61. - PubMed
    1. Nocturne G, Mariette X. Sjogren Syndrome-associated lymphomas: an update on pathogenesis and management. Br J Haematol. 2015;168(3):317–327. - PubMed

Publication types